C12Y 201/02002
Phosphoribosylglycinamide formyltransferase
Official title: Phosphoribosylglycinamide formyltransferase (2.1.2.2)
C12Y201/02002 (Phosphoribosylglycinamide formyltransferase) appears on 2 US grants and 4 published applications in this corpus.
Search patents in C12Y- Granted patents
- 2
- Published applications
- 4
- Assignees
- 4
- Inventors
- 12
- Latest grant
- 20 Jun 2023
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2012 | 0 | 1 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 2 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 1 | 0 |
| 2023 | 1 | 0 |
| 2024 | 0 | 1 |
By publication year.
Recent patents
- P aeruginosa pcrv-linked antigen vaccines2 May 2024US 2024/0139304 A1Glaxosmithkline Biologicals SA
- Method for Producing Objective Substance30 May 2019US 2019/0161776 A1Ajinomoto Co., Inc.
- P aeruginosa pcrv-linked antigen vaccines28 Mar 2019US 2019/0091319 A1Glaxosmithkline Biologicals SA
- Pichia pastoris loci encoding enzymes in the adenine biosynthetic pathway26 Apr 2012US 2012/0100617 A1
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.